Clinexpert Kft.
- Address
- lock Available on a paid plan
Cardiovascular Diseases
At Clinexpert Kft., investigators are exploring innovative approaches to manage atherosclerotic cardiovascular disease and its complications, emphasizing long‑term safety and patient‑centered outcomes.
- Evaluation of novel anti‑inflammatory agents for cardiovascular risk reduction
- Assessment of renal‑cardiac interaction in chronic kidney disease
- Biomarker‑driven strategies to personalize therapy
These studies aim to lower event rates and improve quality of life for individuals at risk of heart disease.
Digestive System Diseases
Research at the site focuses on improving treatment for inflammatory bowel disease and primary biliary cholangitis, seeking therapies that alleviate fatigue and cognitive symptoms while ensuring tolerability.
- Testing new agents for ulcerative colitis with moderate to severe activity
- Investigating therapies that target fatigue in primary biliary cholangitis
- Exploring gut‑focused immunomodulation in gastrointestinal cancers
The goal is to provide better symptom control and disease management for patients with chronic digestive disorders.
Neoplasms
The oncology program evaluates cutting‑edge treatments for cancers such as non‑small cell lung cancer, tumors with KRAS G12C mutation, and high‑risk early‑stage breast cancer, aiming to enhance survival and personalize care.
- Combination immunotherapy for advanced lung cancer
- Targeted agents for KRAS‑mutated solid tumors
- Adjuvant therapies to prevent recurrence in early‑stage breast cancer
- Therapeutic cancer vaccine evaluation after immunotherapy failure
These trials strive to extend patient survival and expand therapeutic options across multiple tumor types.
Nervous System Diseases
Studies address neuropsychiatric challenges by testing novel compounds for agitation in Alzheimer’s disease, with a focus on safety, tolerability, and improvement of daily functioning.
- Evaluating new agents to reduce agitation in dementia patients
- Safety profiling of neuro‑psychiatric medications
- Improving cognitive outcomes and caregiver support
The aim is to enhance quality of life for individuals living with neurodegenerative conditions and their families.
Digestive System and Oral Physiological Phenomena
The site investigates fundamental digestive system physiological processes and their link to oral health, seeking biomarkers and diagnostic tools for early disease detection.
- Studying biomarkers of gastrointestinal function
- Assessing the impact of the oral microbiome on systemic disease
- Developing diagnostic assays for early detection of digestive disorders
Findings may lead to earlier interventions and targeted therapies for both oral and gastrointestinal health.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Eli Lilly & Co.3active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Eli Lilly & Co.3trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 332 other sites in Hungary
Therapeutic Area Benchmark — Hungary
Select a therapeutic area to compare against other sites in Hungary.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Hungary
Market Share
Country: Hungary
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Clinexpert Kft.
lock Showing 1 of 11 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of AZD7798 in Moderate to Severe Crohn's Disease: A Double-Blind, Placebo-Controlled Phase IIa Clinical Trial | AstraZeneca AB | Phase II | Not Recruiting | Nov 2024 | — |
IMP list
lock Showing 1 of 11 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Mirikizumab | 2 | Unknown | 2025-02-25 | 2026-03-31 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.